[videojs_hls url=’//du7x25at22z7c.cloudfront.net/470328/index_HLSv3.m3u8′ poster=’http://www.finnewsnetwork.com.au/newssystem/2024/Int_DEV_360_240730.jpg’]
Brendan Bradley – Managing Director – DevEx Resources (ASX:DEV) is an exploration company with a diversified portfolio of high-quality projects spanning some of Australia’s best endowed mining regions.
Copyright 2024 – Finance News Network
Source: Finance News Network
13 Aug 2025 - CEO and Managing Director Mark Freeman and Portfolio Manager Kieran Kennedy discuss the FY25 full-year results of Mirrabooka Investments (ASX:MIR).
Read More06 Jan 2021 - Nyrada Limited (ASX:NYR) CEO James Bonnar discusses the cholesterol-lowering market, and recent results for the company's lead drug candidate, which achieved a 57% reduction in total cholesterol.
Read More19 Mar 2025 - Michael Fazzini, Sales and Distribution Executive at Capital Prudential, discusses the company's strategy.
Read More31 Jul 2023 - Sequoia Asset Management Investment Manager Winston Sammut discusses property opportunities and pitfalls in the current economic climate.
Read More10 Jun 2021 - Calima Energy Limited (ASX:CE1) Executive Chairman Glenn Whiddon provides an update on production at the company's projects in British Columbia and its plans for an active, low-risk drilling program developing proven reserves.
Read More16 Jun 2020 - Zelira Therapeutics Limited (ASX:ZLD) Managing Director Ex USA, Dr Richard Hopkins talks about the company's pipeline of products in clinical development targeting insomnia, chronic pain and autism, its model for rapid commercialisation, its go-to-market strategy and first revenues from US licensing partners.
Read More25 Jul 2023 - BluGlass Limited (ASX:BLG) CEO Jim Haden provides an update on the company, discussing customers and market, product improvements, vertical integration and roadmap.
Read More16 Oct 2024 - Rita Gatt, National Lead Partner - Regulation, Security and Risk at Deloitte, discusses the revolutionary potential of quantum computing.
Read More12 Mar 2025 - The launch of Sofdra and what's next for Botanix
Read More25 Mar 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt provides an update on the company's pipeline of clinical trials, focusing on results in head and neck cancer, lung cancer and breast cancer.
Read More
